Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2019

Dec 2, 2019

34975_dirs_2019-12-02_3facc052-3829-4eb4-83a3-5db264f44796.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2019-11-01

Reporting Person: EDRICK ALAN I (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-11-01 Common Stock A 600 $0.00 Acquired 31800 Direct

Footnotes

F1: Represents a deferred stock award of 600 restricted stock units which vest in full on December 31, 2019. This retainer award was granted under the Issuer's director compensation policy in connection with the director being added to the Audit Committee on October 31, 2019. The award is pro-rated in relation to service on the committee for the remainder of 2019. The number of shares of common stock subject to such retainer award is equal to the amount of cash that would have been received had the applicable retainer all been paid in cash, divided by the average daily closing market price of the Issuer's common stock for the month of August, rounded to the nearest 100 shares.

F2: Includes (a) a deferred stock award of 600 restricted stock units which vest in full on December 31, 2019 as described in footnote 1 above, (b) a deferred stock award of 5,800 which vest in full on December 31, 2019; and (c) 25,400 shares of common stock held by the Reporting Person.